About CCS
Center Watch Article

 
Cardiovascular Core Laboratories

CCS offers the following cardiovascular core laboratory services:

  • Study Protocol, CRFs, Site Operating Manual
  • Site Training
    • Investigator Meeting
    • Site Conference Call
  • Data Transfer Protocol
  • Site Communication
  • QC Images and Follow Up After Each Study
  • Status Updates and Reports to Sponsor

Current Core Lab Trials:

Hemodynamic Tracings

  • Acute Decompensated Heart Failure Pivotal – Device, Chronic HF, 200 Patients, 80 Tracings / patient, 40 Sites, Enrolling

SPECT MPI

  • Myocardial Stem Cell Phase I - Drug/Device, Chronic HF, 35 Patients, 3 Time Points, 3 Sites, Near Completion
  • Myocardial Stem Cell Phase II – 150 Patients, 3 Time Points, 15 Sites, 18-24 Months

Echocardiography

  • Familial Amyloid Cardiomyopathy Phase 0 – Natural History, Protein Misfolding, 35 Patients, 5 Time Points, 5-7 Sites, 2 Years
  • Pediatric Leukemia Phase I/II – Drug, 40 Patients, 9 Time Points, 7 Sites, 2 Years

MEMS Cap

  • Chronic Heart Failure Phase IIIb – Drug, 400 Patients, 1 or 2 Caps/Patient, 50 Sites, Enrollment Complete

[ About CCS ] [ Currently Enrolling Studies ] [ Additional Resources ]
[ Career Opportunities ] [ Contact CCS ] [ Sites Only ] [ Sponsors Only ] [ Home ]

Copyright© 2007 Cardiovascular Clinical Studies
All Rights Reserved